Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TJP-008-1
- Development stage
- Unknown
- Lead developer
- Taejoon Pharmaceutical
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Oral
01
Overview
**TJP-008-1** is the one-day, morning-only split-dose regimen of Taejoon Pharmaceutical’s low-volume oral bowel-cleansing product TJP-008, marketed as CleanViewAL. The fixed-dose powder preparation combines polyethylene glycol 3350 with high-dose ascorbate and electrolyte salts; after dissolution in water, it produces an osmotic laxative effect that retains water in the intestinal lumen and promotes rapid colonic evacuation before colonoscopy. TJP-008-1 was evaluated in a randomized, evaluator-blinded Phase 3 trial versus the evening-morning TJP-008-2 regimen and a 2-liter PEG-plus-ascorbate comparator, with noninferior bowel-cleansing efficacy. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8924813/))
- Brand names
- CleanViewAL
- Other names
- 1-day split dose CleanViewALsame-day split dose CleanViewAL
Beyond the preview
Go deeper on TJP-008-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TJP-008-1.